The EVERY Company
| Company type | Private |
|---|---|
| Industry | Biotechnology, Food technology |
| Founded | 2015 |
| Founder | Arturo Elizondo, Dave Anchel |
| Headquarters | South San Francisco, California , United States |
| Products | Animal-free egg white ingredient, bioidentical animal-free pepsin enzyme, animal-free protein ingredients |
The EVERY Company (previously known as Clara Foods Co.) is a biotechnology enterprise located in the United States that focuses on producing proteins traditionally sourced from animals, but without using any animal inputs. By employing yeast fermentation, the company transforms sugars into proteins that are molecularly identical to those found in animal-derived products.
Established in 2015 with its main office in South San Francisco, California, The EVERY Company is dedicated to advancing the adoption of sustainable, animal-free protein alternatives and minimizing reliance on industrial animal farming. It offers commercial clients animal-free ingredients designed to mimic both the flavor and functional properties of conventional animal-based components.
History
The EVERY Company was created by Arturo Elizondo and Dave Anchel, who connected at a conference in 2014. They pioneered microbial fermentation techniques to produce egg proteins without using chickens and joined the first group of SOSV's biotech accelerator IndieBio.
In 2019, the company received investment from Grupo Bimbo, recognized as the largest bakery globally. The EVERY Company introduced its initial product, a digestive health supplement, in 2020.
By April 2021, The EVERY Company collaborated with ZX Ventures, the innovation branch of brewing leader AB InBev, to expand production capacity of its unique egg protein via fermentation processes at scales comparable to AB InBev’s brewery operations. This collaboration represented AB InBev’s inaugural partnership within the food sector.
In 2023, actress Anne Hathaway made her initial business-to-business investment by supporting The EVERY Company, motivated by her strong conviction in advancing innovations within the food industry.
The company created the first animal-free egg white ingredient that serves as a replacement for traditional eggs across applications such as baking, nutrition, and industrial uses. This product exhibits foaming, gelling, and binding characteristics similar to conventional egg whites, enabling the manufacture of vegan versions of egg-based foods including meringues and scrambled eggs.
Furthermore, The EVERY Company developed the first bioidentical animal-free pepsin enzyme for pharmaceutical purposes, facilitating vegan-friendly alternatives in medications requiring this enzyme.
In 2022, Every EggWhite was launched by The EVERY Company as an animal-free egg substitute targeting bakery industry clients. Its performance has been validated in bakery items like macarons.